• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性型脱发

Female pattern hair loss.

作者信息

Chan Linda, Cook David K

机构信息

MBBS, Senior Medical Resident Officer, Concord Repatriation General Hospital, Sydney Local Health District, NSW.

MBBS, FACD, Consultant Dermatologist at Concord Repatriation General Hospital, Clinical Senior Lecturer @ The Sydney University Concord Clinical School, NSW.

出版信息

Aust J Gen Pract. 2018 Jul;47(7):459-464. doi: 10.31128/AJGP-02-18-4498.

DOI:10.31128/AJGP-02-18-4498
PMID:30114864
Abstract

BACKGROUND

Female pattern hair loss (FPHL) is a commonly encountered clinical presentation in primary care. Patterned hair loss in women is characterised by diffuse hair thinning and often becomes an ongoing cause of psychosocial distress.

OBJECTIVE

The aim of this article is to present a practical approach for the clinical assessment of female hair loss and to review the up-to-date treatment modalities.

DISCUSSION

Alopecia can be the first symptom of systemic illness. It is therefore crucial for the primary care physician to be able to differentiate between FPHL and more concerning causes of hair loss. Treatment options often involve a combination of non-androgenic and androgenic therapy. The use of oral minoxidil in combination with oral spironolactone is a novel therapy with promising results. The role of the general practitioner is paramount in establishing the diagnosis, setting achievable therapeutic goals and navigating the psychosocial comorbidity associated with this chronic condition.

摘要

背景

女性型脱发(FPHL)是初级保健中常见的临床表现。女性的型态性脱发以弥漫性头发稀疏为特征,并且常常成为心理社会困扰的持续原因。

目的

本文的目的是介绍一种女性脱发临床评估的实用方法,并综述最新的治疗方式。

讨论

脱发可能是全身性疾病的首发症状。因此,对于初级保健医生而言,能够区分女性型脱发和更令人担忧的脱发原因至关重要。治疗选择通常涉及非雄激素和雄激素疗法的联合使用。口服米诺地尔与口服螺内酯联合使用是一种有前景的新型疗法。全科医生在确立诊断、设定可实现的治疗目标以及应对与这种慢性病相关的心理社会合并症方面的作用至关重要。

相似文献

1
Female pattern hair loss.女性型脱发
Aust J Gen Pract. 2018 Jul;47(7):459-464. doi: 10.31128/AJGP-02-18-4498.
2
Female pattern hair loss.女性型脱发
Curr Probl Dermatol. 2015;47:45-54. doi: 10.1159/000369404. Epub 2015 Feb 20.
3
Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.0.25%非那雄胺和 3%米诺地尔联合外用治疗女性型脱发的疗效:一项随机、双盲、对照研究。
Am J Clin Dermatol. 2019 Feb;20(1):147-153. doi: 10.1007/s40257-018-0387-0.
4
Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee.女性型脱发与雄激素过多:多学科雄激素过多与多囊卵巢综合征委员会的报告。
J Clin Endocrinol Metab. 2019 Jul 1;104(7):2875-2891. doi: 10.1210/jc.2018-02548.
5
Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone.女性型脱发:一项低剂量口服米诺地尔和螺内酯联合治疗的初步研究。
Int J Dermatol. 2018 Jan;57(1):104-109. doi: 10.1111/ijd.13838. Epub 2017 Dec 12.
6
Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness.女性脱发:增加头皮毛发丰满度的医学和美容方法。
Br J Dermatol. 2011 Dec;165 Suppl 3:12-8. doi: 10.1111/j.1365-2133.2011.10630.x.
7
Treatment of female pattern hair loss with the androgen receptor antagonist flutamide.雄激素受体拮抗剂氟他胺治疗女性型脱发。
Australas J Dermatol. 2011 May;52(2):132-4. doi: 10.1111/j.1440-0960.2010.00735.x. Epub 2011 Mar 1.
8
Hair loss in women.女性脱发
Clin Obstet Gynecol. 2015 Mar;58(1):185-99. doi: 10.1097/GRF.0000000000000081.
9
Treatment of female pattern hair loss with a combination of spironolactone and minoxidil.螺内酯与米诺地尔联合治疗女性型脱发
Australas J Dermatol. 2007 Feb;48(1):43-5. doi: 10.1111/j.1440-0960.2007.00332.x.
10
Female pattern hair loss.女性型脱发。
Indian J Dermatol Venereol Leprol. 2013 Sep-Oct;79(5):626-40. doi: 10.4103/0378-6323.116732.

引用本文的文献

1
Male and female pattern hair loss.男性型脱发和女性型脱发。
Aust Prescr. 2025 Jun;48(3):93-97. doi: 10.18773/austprescr.2025.020.
2
Frontal Fibrosing Alopecia and Reproductive Health: Assessing the Role of Sex Hormones in Disease Development.额部纤维性秃发与生殖健康:评估性激素在疾病发展中的作用
J Pers Med. 2024 Jan 5;14(1):72. doi: 10.3390/jpm14010072.
3
Age-Related Macular Degeneration in Patients with Androgenetic Alopecia: Could the Monocyte/HDL Ratio Be the Link?雄激素性脱发患者的年龄相关性黄斑变性:单核细胞/高密度脂蛋白比值会是其中的关联因素吗?
Dermatol Pract Concept. 2023 Oct 1;13(4):e2023285. doi: 10.5826/dpc.1304a285.
4
Female Pattern Hair Loss and Negative Psychological Impact: Possible Role of Brain-derived Neurotrophic Factor (BDNF).女性型脱发与负面心理影响:脑源性神经营养因子(BDNF)的潜在作用
Dermatol Pract Concept. 2023 Jul 1;13(3):e2023139. doi: 10.5826/dpc.1303a139.
5
Human Stem Cell Use in Androgenetic Alopecia: A Systematic Review.雄激素性脱发中应用人干细胞:系统评价。
Cells. 2023 Mar 21;12(6):951. doi: 10.3390/cells12060951.
6
Telogen effluvium after COVID-19 vaccination among public in Saudi Arabia.沙特阿拉伯公众接种新冠疫苗后出现的休止期脱发
J Family Med Prim Care. 2022 Oct;11(10):6056-6060. doi: 10.4103/jfmpc.jfmpc_377_22. Epub 2022 Oct 31.
7
The Predictive Value of Midscalp Hair Density and Terminal Hair Percentage in the Severity Evaluation of FPHL Assessed by Trichoscan in a Sample of Chinese Population.在一组中国人群样本中,通过毛发扫描仪评估中头皮毛发密度和终毛百分比在女性型雄激素性脱发严重程度评估中的预测价值。
Clin Cosmet Investig Dermatol. 2022 Dec 13;15:2675-2684. doi: 10.2147/CCID.S390148. eCollection 2022.
8
Advancing Regenerative Cellular Therapies in Non-Scarring Alopecia.推进非瘢痕性脱发的再生细胞疗法。
Pharmaceutics. 2022 Mar 10;14(3):612. doi: 10.3390/pharmaceutics14030612.
9
Is There Any Association Between Clinical and Biochemical Hyperandrogenism in Women With Female Pattern Hair Loss?女性型脱发女性的临床和生化高雄激素血症之间是否存在关联?
Cureus. 2020 Nov 27;12(11):e11732. doi: 10.7759/cureus.11732.